The Skin Cancer Foundation

Skin cancer is the most prevalent of all types of cancers. It is estimated that more than one million Americans develop skin cancer every year.

Skin Cancer Signs, Symptoms, Causes, Treatment, Prevention and ...

Many Strategic Possibilities in Prostrate Cancer R&D.

By Anonymous

February 7 2004--Research and Markets announces the addition of this exciting new report entitled "Analysis of Prostate Cancer R&D: The Complete Guide" to its offerings.

According to the American Cancer Society, after skin cancer, prostate cancer is the most common type of cancer found in American men and is the second leading cause of cancer deaths in men, exceeded only by lung cancer.

Analysis of Prostate Cancer R&D - the Complete Guide offers a unique tool for analysing the vast amount of strategic possibilities that have emerged in prostate cancer R&D.This tool provides an immense amount of structured information. Innovative cancer therapies such as antisense, monoclonal antibodies, gene therapy, antigen- or cellular-based vaccines, liposomal hormones and apoptotic drugs are analyzed in more than 100 extensive tables and graphs. "Analysis of Prostate Cancer R&D - the Complete Guide" gives you easy-to-read tables with projects classified into well-defined structures based on type of therapy given, effect and mechanism. The graphs provide all the relations of these factors as well as the general and specific trends in the current prostate cancer pipeline.

For a complete index of this report click on http://www.researchandmarkets.com/reports/44928

About Research and Markets Ltd.
Research and Markets Ltd. are Europe's largest resource for market research. R&M distribute thousands of major research publications from the world's leading publishers, consultants and market analysts. R&M provide you with the latest forecasts on international and regional markets, key industries, the top companies, new products and the latest market trends.

For additional information on ResearchandMarkets.com, their range of reports or their value-added services, visit their web site at http://www.researchandmarkets.com or mailto:press@researchandmarkets.com




This article courtesy of http://typesofskincancerdata.info/.
You may freely reprint this article on your website or in
your newsletter provided this courtesy notice and the author
name and URL remain intact.

Discovery-Selenium Supplementation May Reduce Cancer Risk

By Anonymous

San Diego, CA January 18 2004--One in every four deaths in this country is caused by cancer. That’s 1,500 people each day. Many of these cancers are caused by our own bad behaviors - tobacco and alcohol use, lack of exercise, and poor diet - which has led researchers to investigate the ability of nutritional supplements to reduce cancer risk.

For example, there's now convincing evidence that selenium (an essential mineral found in various foods such as Brazil nuts and mushrooms) when taken daily as a supplement can significantly reduce the risk of cancer. In one clinical study, the risk of prostate cancer was reduced 63% in men supplementing with selenium compared to a placebo group. This result has created tremendous interest in the medical community and the National Cancer Institute has funded a much larger study called SELECT (Selenium and Vitamin E Cancer Prevention Trial) that will enroll 32,000 male subjects to better determine selenium’s ability to prevent cancer. For more information about SELECT and the selenium-prostate cancer link, visit www.crab.org/select/ and www.pcacoalition.com.

Selenium supplementation seems to protect against other cancers as well. According to the Journal of Agricultural and Food Chemistry, research suggests that selenium can also protect humans against cancer of the lung, ovaries, breast, colon, liver, cervix, skin, stomach and uterus. When sufficient selenium levels are achieved, the risk of getting cancer is half that of a person who is selenium deficient.

With the exception of Brazil nuts, there are few good food sources of selenium, so supplementation may be the best way to attain selenium’s protective benefits. One company expected to gain substantially from this surge in selenium interest is Eidon Inc., a San Diego company that has developed a selenium supplement in liquid form which the company says is flavorless and odorless, and can be taken alone or mixed with a favorite drink. Richard Wagner, Eidon’s president, said “We’ve seen so much interest in our selenium supplements recently, that we’ve had to seek out additional suppliers to make sure we can keep up with expected demand”.

As more people become aware of the research demonstrating selenium’s health benefits, there can be no doubt that Mr. Wagner’s concern is real.

Eidon products are available at select health food stores, online at www.eidon.com, or direct at 800-700-1169.

For additional research, public information or liquid minerals, contact:
Rick Wagner
Eidon Inc.
(858) 578-7288
www.eidon.com




This article courtesy of http://typesofskincancerdata.info/.
You may freely reprint this article on your website or in
your newsletter provided this courtesy notice and the author
name and URL remain intact.

Emphasize skin self-exams during melanoma month in May

By Anonymous

February 27, 2004 -- Sloan-Kettering researchers note that self exams may reduce melanoma death by 63%.

Advanced Dermatology PC, 2004 – The American Academy of Dermatology (AAD) has designated May as Melanoma Month, to heighten awareness of the deadliest form of skin cancer. This year, the comments of researchers at Sloan-Kettering Memorial Cancer Center in NY – suggesting that Skin Self Examination (SSE) can reduce melanoma-related deaths by 63% -- will likely place the focus of Melanoma Month squarely on preventative measures.

Dr. Joshua Fox, an official spokesperson for the AAD and founding director of Advanced Dermatology and The Center for Laser and Cosmetic Surgery in NY, confirms, “We have been recommending Skin Self Examination (SSE) as part of our patient education program for years. But, considering the lethal and tricky nature of melanoma, we must now step up our efforts even further.”

Dr. Fox points out that melanoma is the deadliest skin cancer because it is the one most likely to metastasize. It is also difficult for patients to detect, because it evolves as a new mole, or as changes to an existing mole. Without regular Skin Self Examinations, patients can easily miss the signs that melanoma has developed.

Recognizing those signs can indeed have lifesaving results. In a study conducted at Memorial Sloan-Kettering Cancer Center in New York, NY and reported in the February issue of the American Journal of Preventative Medicine, researchers noted: “Results from a single case-control study suggest that skin self-examination (SSE) has the potential to reduce mortality from melanoma by 63%. Despite these encouraging results, SSE rates are low.”

Considering the hopeful statistics, the Sloan Kettering researchers designed a 100-patient study to determine factors that could increase their compliance with Skin Self Examination protocols. Researchers found that, by using such novel aids as baseline, whole-body photography and intervention by a health care professional, regular Skin Self Examination rates increased by over 50%. Using a baseline photo book alone as a guide for SSE increased the rate by 17%.

Dr. Fox recommends taking baseline photographs of suspicious areas before beginning a regular Skin Self Examination routine. He then encourages his patients to view each mole critically, using the “ABCD” approach:

- Appearance: has a mole developed suddenly on previously clear skin, or has an existing mole changed its appearance?

- Border: Is the border of the mole asymmetric (if you divide the mole in half, do the sides match in shape) or jagged?

- Color: Is the mole uniform in color, or is it flecked with darker black and/or red areas? Has its color changed or deepened?

- Diameter: Has the mole grown in size or become raised? Is it larger than the size of a pencil’s eraser?

“While these signs do not confirm the existence of melanoma, they are definite indicators that the mole should be checked by a dermatologist immediately,” Dr. Fox notes. He adds, “Timing is crucial. When melanoma is caught early, when it has not invaded the deep layers of skin, it is nearly 100% curable. However, when it has metastasized to distant organs, the five-year survival rate drops to a mere 12%.”

The AAD estimates that more than 51,000 cases of melanoma are diagnosed each year, and the disease claims nearly 8,000 lives annually. Virtually all people are at risk for melanoma. Those in the highest risk groups include:

- people with a family history of melanoma (parents, siblings and/or children)

- people who have had multiple sunburns and/or extended unprotected exposure to harmful UV rays from the sun and/or tanning beds

- those who have fair complexions, or who tan poorly or not at all

- those with a large number of moles and/or atypical moles on their skin

“Just as we have found the key to surviving breast cancer is through early detection, so have we determined that Skin Self Examination can dramatically reduce the mortality rate for melanoma, by early recognition and treatment leading to cures” Dr. Fox notes. “Simply by increasing the rate at which people comply with simple self exams, we can take a big step forward in stopping this deadly form of skin cancer.”

Bio: Joshua L. Fox, M.D.
Joshua L. Fox, M.D. is a leading authority in the field of dermatology with an expertise in skin cancer, cosmetic surgery, and laser procedures. As an official spokesperson for the American Academy of Dermatology and the American Society of Dermatologic Surgery, Dr. Fox has been an expert resource on dermatologic topics for numerous television networks including ABC, CBS, CNN, NBC, Telemundo, talk shows, radio stations, newspapers and magazines. Dr. Fox has served on the board of the National Rosacea Foundation and has done clinical trials in both medical and laser therapy in Rosacea. He has received multiple research and clinical awards including recognition from Top Doctors, Who's Who, Journal of Dermatologic Surgery and Oncology, Community Service Award from the American Society of Dermatologic Surgery, the prestigious Husic Award as well certificates of recognition for service from multiple hospitals, civic, educational and community organizations. Dr. Fox has authored and presented papers of his research on lasers, cosmetic procedures, stretch marks, scars, skin cancer, bug bites, photosensitivity and various rashes.

As founder and director of Advanced Dermatology and The Center for Laser and Cosmetic Surgery, Dr. Fox and associates have expanded the practice to the one of largest in dermatology, laser & cosmetic surgery with more lasers than any hospital or dermatology practice on the eastern coast. Dr. Fox is a graduate of the New York University Medical Center of Skin and Cancer and has been on the advisory board of the Psoriasis Foundation and National Rosacea Foundation among others. He has also been a fellow of many societies including the International Academy of Cosmetic Surgery, International Academy of Cosmetic Dermatology, and the Society for Investigative Dermatology. Dr. Fox is the founder of the AAD Melanoma/Skin Cancer Prevention Program in Queens, New York since 1987. Dr. Fox has been Chief of Dermatology of several major teaching hospitals including Mt. Sinai Hospital of Queens and Jamaica Medical Center and is currently on the staff of ten NY area hospitals. Dr. Fox and Advanced Dermatology the Center for Laser & Cosmetic Surgery have been used as a resource center educating dermatologists, laser surgeons, & cosmetic surgeons and others about lasers, cancer and cosmetic surgery.



This article courtesy of http://typesofskincancerdata.info/.
You may freely reprint this article on your website or in
your newsletter provided this courtesy notice and the author
name and URL remain intact.